Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Feb. - May 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2004
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 2003
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Test material form:
- liquid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST SYSTEM
Species: Mouse, CBA strain, inbred, SPF-Quality. Recognized by the international guidelines as the recommended test system (e.g. OECD, EC, EPA).
Source: Charles River France, L’Arbresle Cedex, France
Number of animals: 20 females (nulliparous and non-pregnant), five females per group.
Age and bodyweight: Young adult animals (approx. 10 weeks old) were selected. Body weight variation was within +/- 20% of the sex mean.
Identification: Tail mark with marker pen.
Health inspection: A health inspection was performed prior to treatment, to ensure that the animals are in a good state of health. Special attention was paid to the ears, which were intact and free from any abnormality.
ANIMAL HUSBANDRY
Conditions: Animals were housed in a controlled environment, in which optimal conditions were considered to be approximately 15 air changes per hour, a temperature of 21.0 ± 3.0°C (actual range: 20.6 - 23.2°C), a relative humidity of 30-70% (actual range: 35 - 63%) and 12 hours artificial
fluorescent light and 12 hours darkness per day.
Accommodation: Individual housing in labeled Macrolon cages (MI type; height 12.5 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France).
Acclimatization period: The acclimatization period was at least 5 days before the start of treatment under laboratory conditions. Accommodation was as described above except that the animals were group housed in Macrolon cages (MIII type; height 18 cm). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied as cage-enrichment.
Diet: Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
Water: Free access to tap water.
Results of analysis for each batch of diet (nutrients) and results of quarterly analysis of diet (contaminants), sawdust, paper and water were assessed and did not reveal any findings that were considered to have affected the study integrity. All certificates and results of analysis are retained in the NOTOX archives.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100%
- No. of animals per dose:
- 5
- Details on study design:
- Preliminary irritation study:
A preliminary irritation study was conducted in order to select the highest test substance concentration to be used in the main study. In principle, this concentration should be well tolerated systemically by the animals and may give moderate irritation (grade 2) at the highest.
A series of two test substance concentrations was tested, selected from the series: 100% (undiluted), 50%, 25%, 10%, 5%, 2.5%, 1% and if needed further lower concentrations using the same steps. The highest concentration, selected from this series, was the undiluted test substance.
The test system, procedures and techniques were identical to those used during Days 1 to 3 of the main study unless otherwise specified. Two young adult animals were selected (5-14 weeks old). Each animal was treated with one concentration on three consecutive days. Approximately 4 hours after the last exposure, the ear was cleaned of residual test substance with tap water and the irritation was assessed. Bodyweights were determined on Day 3. The animals were sacrificed after the final observation and no necropsy was performed.
Main study:
Three groups of five animals were treated with one test substance concentration per group. The highest test substance concentration was selected from the preliminary irritation study. One group of five animals was treated with vehicle.
Allocation:
Group*1 animal numbers induction (% test substance)
1 01 - 05 0% (Acetone/Olive oil (4:1 v/v) )
2 06 - 10 25%
3 11 - 15 50%
4 16 - 20 100%
*1 five females each group
Induction - Days 1, 2 and 3:
The dorsal surface of both ears was epidermally treated (25 µl/ear) with the test substance
concentration, at approximately the same time per day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The control animals were treated the same as the experimental animals, except that, instead of the test substance, the vehicle alone was administered.
Treatment - Day 6:
All animals: Each animal was injected via the tail vein with 0.25 ml of sterile phosphate buffered saline (PBS) (Merck, Darmstadt, Germany) containing 20 µCi of 3H-methyl thymidine (GE Health care Buckinghamshire, UK). After approximately five hours, all animals were killed by intraperitoneal injection with pentobarbital (0.2 ml/animal Euthesate®; Sanofi Sante SV, Maassluis, The Netherlands). The draining (auricular) Iymph node of each ear was excised, The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3 ml PBS.
Tissue processing for radioactivity - Day 6:
A single cell suspension of Iymph node cells (LNC) was prepared in PBS by gentle separation
through stainless steel gauze (diameter 125 µm). LNC were washed twice with an excess of PBS by centrifugation at 200 g for 10 minutes. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) (Merck, Darmstadt, Germany) at 4° C during the night.
Radioactivity measurements - Day 7:
Precipitates were recovered by centrifugation, resuspended in 1 ml TCA and transferred to 10
ml of Ultima Gold cocktail (PerkinEImer Life and Analytical Sciences, Boston, MA, US) as the
scintillation fluid. Radioactive measurements were performed using a Packard scintillation
counter (2800TR). Counting time was to a statistical precision of ± 0.2% or a maximum of 5
minutes whichever comes first. The Packard 2800TR was programmed to automatically subtract
background and convert Counts Per Minute (CPM) to Disintegrations Per Minute (DPM).
Observations:
Mortality/Viability: Twice daily.
Toxicity: At least once daily.
Body weights: On Days 1 (pre-treatment) and 6.
Irritation: On Day 3 (3-4 hours after treatment), the skin reactions were assessed. Skin reactions were graded according to the following numerical scoring system. Furthermore descriptions of all other (Iocal) effects were recorded.
Grading Irritation Reactions:
Erythema and eschar formation:
No erythema ..................................................................................................................... 0
Slight erythema (barely perceptible) ............................................. ................................. 1
Well-defined erythema ..................................................................................................... 2
Severe erythema (beet redness) to slight eschar formation (injuries in depth) ...........3
Oedema formation:
No oedema ....................................................................................................................... 0
Slight oedema (barely perceptible) ................................................................................. 1
Moderate oedema............................................................................................................. 2
Severe oedema ................................................................................................................. 3 - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The EC3 value (the estimated test substance concentration that will give a SI =3) was determined, using linear interpolation.
Basketter DA, Lea LJ, Dickens A, Briggs, D, Pate I, Dearman RJ and Kimber I. A
comparison of statistical approaches to the derivation of EC3 values from locallymph node
assay dose responses. J Appl ToxicoI1999;19:261-266.
Results and discussion
- Positive control results:
- Reliability Check:
group treatment induction mean SI ± SEM
DPM ± SEM
2 experimental 5% test substance 249 ± 34 1.4 ± 0.3
3 experimental 10% test substance 393 ± 56 2.2 ± 0.3
4 experimental 25% test substance 1107 ± 243 6.1 ± 0.3
1 vehicle control Acetone : Olive oil (4:1) 183 ± 43 1.0
*. five females each group
group 2 | treatment experimental | induction 5% test substance | mean (DPM ± SEM) 249 ± 34 | SI ± SEM 1.4 ± 0.3;
group 3 | treatment experimental | induction 10% test substance | mean (DPM ± SEM) 393 ± 56 | SI ± SEM 2.2 ± 0.3;
group 4 | treatment experimental | induction 25% test substance | mean (DPM ± SEM) 1107 ± 243 | SI ± SEM 6.1 ± 0.3;
group 1 | treatment vehicle control | Acetone : Olive oil (4:1) | mean (DPM ± SEM) 183 ± 43 | SI ± SEM 1.0;
CONCLUSION
The SI values calculated for the substance concentrations 5, 10 and 25% were 1.4, 2.2 and 6.2 respectively. An EC3 value of 13.1% was calculated using linear interpolation. The calculated EC3 value was found to be in the acceptable range of 2 and 20%. The results of the 6 monthly HCA reliability checks of the recent years were 8.8, 5.5, 7.3 and 10.3%. Based on the results, it was concluded that the Local Lymph Node Assay as performed at NOTOX is an appropriate model for testing for contact hypersensitivity.
The raw data, protocol and report from this study are kept in the NOTOX archives. The test described above was performed in accordance with NOTOX Standard Operating Procedures and the report was audited by the QA-unit.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- EC3
- Value:
- 32.9
- Parameter:
- SI
- Value:
- 2.3
- Variability:
- SEM: ± 0.9
- Test group / Remarks:
- group 2: 25% test substance (Vehicle: Acetone/Olive oil (4:1 v/v))
- Parameter:
- SI
- Value:
- 4.4
- Variability:
- SEM: ± 1.7
- Test group / Remarks:
- group 3: 50% test substance (Vehicle: Acetone/Olive oil (4:1 v/v))
- Parameter:
- SI
- Value:
- 8.5
- Variability:
- SEM: ± 2.6
- Test group / Remarks:
- group 4: 100% test substance
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- group 1: 0% test substance; vehicle control (Vehicle: Acetone/Olive oil (4:1 v/v))
- Parameter:
- other: Disintegration per minute (DPM)
- Value:
- 710
- Variability:
- SEM: ± 204
- Test group / Remarks:
- group 2: 25% test substance (Vehicle: Acetone/Olive oil (4:1 v/v))
- Parameter:
- other: Disintegration per minute (DPM)
- Value:
- 1 371
- Variability:
- SEM: ± 353
- Test group / Remarks:
- group 3: 50% test substance (Vehicle: Acetone/Olive oil (4:1 v/v))
- Parameter:
- other: Disintegration per minute (DPM)
- Value:
- 2 669
- Variability:
- SEM: ± 255
- Test group / Remarks:
- group 4: 100% test substance
- Parameter:
- other: Disintegration per minute
- Value:
- 313
- Variability:
- SEM: ± 91
- Test group / Remarks:
- group 1: 0% test substance; vehicle control (Vehicle: Acetone/Olive oil (4:1 v/v) )
- Cellular proliferation data / Observations:
- Mean DPM/animal values for the experimental groups treated with test substance
concentrations 25, 50 and 100% were 710, 1371 and 2669 respectively.
The mean DPM/animal value for the vehicle contral group was 313.
Any other information on results incl. tables
PRELIMINARY IRRITATION STUDY
Skin reactions after epidermal exposure and body weights
animal number |
% test substance1 |
Day 1 |
|
Day 3 |
||||
Body weight (g) |
|
skin reactions dorsal surface ear |
Body weight (g) |
|||||
|
left |
right |
||||||
|
erythema |
oedema |
erythema |
oedema |
||||
|
|
|
|
|
|
|
|
|
1 |
50 |
25 |
|
2 |
0 |
1 |
0 |
24 |
2 |
100 |
22 |
|
1 |
0 |
2 |
0 |
22 |
|
|
|
|
|
|
|
|
|
1. Vehicle:Acetone/Olive oil (4:1 v/v) .
MAIN STUDY
Skin reactions, body weights and relative size auricular lymph nodes
group
|
% test substance1 |
an2 |
|
Day1 |
|
Day3 |
|
Day6 |
||||||
|
bw (g)3 |
|
skin reactions dorsal surface ear |
|
bw (g)3 |
|
size nodes4 |
|||||||
|
|
left |
right |
|
|
left |
right |
|||||||
|
|
erythema |
oedema |
erythema |
oedema |
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
0% |
1 |
|
22 |
|
0 |
0 |
0 |
0 |
|
22 |
|
n |
n |
|
(vehicle) |
2 |
|
24 |
|
0 |
0 |
0 |
0 |
|
22 |
|
n |
n |
|
|
3 |
|
20 |
|
0 |
0 |
0 |
0 |
|
19 |
|
n |
n |
|
|
4 |
|
21 |
|
0 |
0 |
0 |
0 |
|
22 |
|
n |
n |
|
|
5 |
|
23 |
|
0 |
0 |
0 |
0 |
|
22 |
|
n |
n |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
25% |
6 |
|
21 |
|
1 |
0 |
1 |
0 |
|
20 |
|
n |
n |
|
|
7 |
|
24 |
|
1 |
0 |
1 |
0 |
|
24 |
|
- |
n |
|
|
8 |
|
24 |
|
1 |
0 |
1 |
0 |
|
25 |
|
n |
n |
|
|
9 |
|
22 |
|
1 |
0 |
1 |
0 |
|
22 |
|
n |
n |
|
|
10 |
|
24 |
|
1 |
0 |
1 |
0 |
|
23 |
|
n |
n |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
50% |
11 |
|
20 |
|
2 |
0 |
1 |
0 |
|
19 |
|
n |
n |
|
|
12 |
|
21 |
|
1 |
0 |
2 |
0 |
|
20 |
|
n |
n |
|
|
13 |
|
22 |
|
2 |
0 |
2 |
0 |
|
21 |
|
n |
n |
|
|
14 |
|
24 |
|
1 |
0 |
1 |
0 |
|
23 |
|
n |
n |
|
|
15 |
|
21 |
|
2 |
0 |
2 |
0 |
|
20 |
|
n |
n |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
100% |
16 |
|
21 |
|
2 |
0 |
2 |
0 |
|
21 |
|
n |
+ |
|
|
17 |
|
22 |
|
2 |
0 |
2 |
0 |
|
23 |
|
n |
n |
|
|
18 |
|
21 |
|
2 |
0 |
2 |
0 |
|
21 |
|
+ |
+ |
|
|
19 |
|
24 |
|
2 |
0 |
2 |
0 |
|
24 |
|
n |
n |
|
|
20 |
|
23 |
|
2 |
0 |
2 |
0 |
|
23 |
|
++ |
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.Vehicle:Acetone/Olive oil (4:1 v/v) .
2. Animal number.
3.Body weight (grams).
4.Relative size auricular lymph nodes (-, -- or ---: degree of reduction, +,++ or +++: degree of enlargement, n: considered to be normal).
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- These results indicate that the test substance could elicit an SI >= 3. The data showed a dose-response and an EC3 value of 32.9% was calculated.
This conclusion should be taken with care, since a dose related increase in irritation of the ears was seen. It is known that irritation might stimulate the nodes, causing a false positive outcome of the local lymph node assay. Based on the laboratory experience, irritation might induce an SI up to approximately 4. The SI of 8.5 in this study was considered indicative for sensitisation.
Based on these results:
- according to the recommendations made in the test guidelines, Sa03 would be regarded as skin sensitizer.
- according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (New York and Geneva, 2003), Sa03 should be classified as skin sensitizer (Category 1).
- according to the ECETOC classification scheme for potency, Sa03 would be regarded as weak skin sensitizer.
- according to the CLP Regulation (CE) 1272/2008, Sa03 should be classified as Skin Sens. 1B. - Executive summary:
Assessment for Contact Hypersensitivity to Sa03 in the Mouse (Local Lymph Node Assay).
The study was carried out based on the guidelines described in:
OECD, Section 4, Health Effects, No.429 (2002),
EC, Council Directive 67/548/EEC, Annex V, B.42 (2004);
EPA, OPPTS 870.2600 (2003) “Skin Sensitisation”.
Test substance concentrations selected for the main study were based on the results of a preliminary study. In the main study, three groups of five experimental animals were treated with test substance concentrations of 25%, 50% or 100% on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (Acetone/Olive oil (4:1 v/v)). Three days after the last exposure, all animals were injected with3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised. After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of Disintegrations Per Minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
A dose related increase in irritation of the ears was seen, from slight erythema in all animals at low dose up to well-defined erythema in all animals at high dose. No oedema was observed in any of the animals examined.
The majority of nodes were considered normal in size, except for the nodes of three animals treated at 100% which were enlarged and one node of one animal treated at 25% was reduced in size.
Mean DPM/animal values for the experimental groups treated with test substance concentrations 25, 50 and 100% were 710, 1371 and 2669 respectively.
The mean DPM/animal value for the vehicle control group was 313.
The SI values calculated for the substance concentrations 25, 50 and 100% were 2.3, 4.4 and 8.5 respectively.
These results indicate that the test substance could elicit an SI >=3. The data showed a dose-response and an EC3 value of 32.9% was calculated.
This conclusion should be taken with care, since a dose related increase in irritation of the ears was seen. It is known that irritation might stimulate the nodes, causing a false positive outcome of the local lymph node assay. Based on the laboratory experience, irritation might induce an SI up to approximately 4. The SI of 8.5 in this study was considered indicative for sensitisation.
Based on these results:
- according to the recommendations made in the test guidelines, Sa03 would be regarded as skin sensitizer.
- according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (New York and Geneva, 2003), Sa03 should be classified as skin sensitizer (Category 1).
- according to the ECETOC classification scheme for potency, Sa03 would be regarded as weak skin sensitizer.
- according to the CLP Regulation (CE) 1272/2008, Sa03 should be classified as Skin Sens. 1B.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies